Poster Session: Chromatic Adaptation to Heterochromatic Illumination von Hellwig, Luke, Fairchild, Mark D.

Volltext

Efficient and Hysteresis-Free Field Effect Modulation of Ambipolarly Doped Vanadium Dioxide Nanowires von Peng, Xingyue, Yang, Yiming, Hou, Yasen, Travaglini, Henry C., Hellwig, Luke, Hihath, Sahar, van Benthem, Klaus, Lee, Kathleen, Liu, Weifeng, Yu, Dong

Volltext

Brightness, lightness, colorfulness, and chroma in CIECAM02 and CAM16 von Hellwig, Luke, Fairchild, Mark D.

Volltext

The brightness of chromatic stimuli von Hellwig, Luke, Stolitzka, Dale, Fairchild, Mark D.

Volltext

Extending CIECAM02 and CAM16 for the Helmholtz–Kohlrausch effect von Hellwig, Luke, Stolitzka, Dale, Fairchild, Mark D.

Volltext

75‐1: Student Paper: Brightness and Vividness of High Dynamic Range Displayed Imagery von Hellwig, Luke, Stolitzka, Dale, Yi, Yongwoo, Fairchild, Mark D.

Volltext

Using Gaussian Spectra to Derive a Hue-linear Color Space von Hellwig, Luke, Fairchild, Mark D.

Volltext

Using Gaussian Spectra to Derive a Hue-linear Color Space von Hellwig, Luke, Fairchild, Mark D.

Volltext

An Advanced Color Model for Evaluating New Display Technologies von Hellwig, Luke, Stolitzka, Dale

Volltext

The basic helix‐loop‐helix transcription factor TCF4 impacts brain architecture as well as neuronal morphology and differentiation von Schoof, Melanie, Hellwig, Malte, Harrison, Luke, Holdhof, Dörthe, Lauffer, Marlen C., Niesen, Judith, Virdi, Sanamjeet, Indenbirken, Daniela, Schüller, Ulrich

Volltext

Pregnancy outcomes and postpartum relapse rates in women with RRMS treated with alemtuzumab in the phase 2 and 3 clinical development program over 16 years von Oh, Jiwon, Achiron, Anat, Celius, Elisabeth G., Chambers, Christina, Derwenskus, Joy, Devonshire, Virginia, Hellwig, Kerstin, Hutton, George J., McCombe, Pamela, Moore, Marie, Rog, David, Schneider, Jean-Raphael, Simm, Renata Faria, Sousa, Livia, Vincent, Stephen G., Chung, Luke, Daizadeh, Nadia, Mitchell, Colin, Compston, D. Alastair S.

Volltext

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature von Harrer, Dennis Christoph, Lüke, Florian, Einspieler, Ingo, Menhart, Karin, Hellwig, Dirk, Utpatel, Kirsten, Herr, Wolfgang, Reichle, Albrecht, Heudobler, Daniel

Volltext

TCF4 (E2-2) harbors tumor suppressive functions in SHH medulloblastoma von Hellwig, Malte, Lauffer, Marlen C., Bockmayr, Michael, Spohn, Michael, Merk, Daniel J., Harrison, Luke, Ahlfeld, Julia, Kitowski, Annabel, Neumann, Julia E., Ohli, Jasmin, Holdhof, Dörthe, Niesen, Judith, Schoof, Melanie, Kool, Marcel, Kraus, Cornelia, Zweier, Christiane, Holmberg, Dan, Schüller, Ulrich

Volltext

Postpartum Relapse After First On-Study Pregnancy in RRMS Patients Treated With Alemtuzumab in the Phase 2 and 3 Clinical Development Program Over 8 Years (169) von Celius, Elisabeth G., Oh, Jiwon, Achiron, Anat, Compston, D Alastair S., Devonshire, Virginia, Hellwig, Kerstin, Hutton, George J., McCombe, Pamela, Moore, Marie, Simm, Renata Faria, Sousa, Livia, Vincent, Stephen G., Chung, Luke, Daizadeh, Nadia, Mitchell, Colin, Rog, David

Volltext

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease von Lüke, Florian, Harrer, Dennis C., Menhart, Karin, Wolff, Daniel, Holler, Ernst, Hellwig, Dirk, Herr, Wolfgang, Grube, Matthias, Vogelhuber, Martin, Reichle, Albrecht, Heudobler, Daniel

Volltext

Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth von Keller, Magdalena, Rohlf, Katharina, Glotzbach, Annika, Leonhardt, Gregor, Lüke, Simon, Derksen, Katharina, Demirci, Özlem, Göçener, Defne, AlWahsh, Mohammad, Lambert, Jörg, Lindskog, Cecilia, Schmidt, Marcus, Brenner, Walburgis, Baumann, Matthias, Zent, Eldar, Zischinsky, Mia-Lisa, Hellwig, Birte, Madjar, Katrin, Rahnenführer, Jörg, Overbeck, Nina, Reinders, Jörg, Cadenas, Cristina, Hengstler, Jan G, Edlund, Karolina, Marchan, Rosemarie

Volltext

Cellular liquid biopsy provides unique chances for disease monitoring, preclinical model generation and therapy adjustment in rare salivary gland cancer patients von Stojanović Gužvić, Nataša, Lüke, Florian, Treitschke, Steffi, Coluccio, Andrea, Hoffmann, Martin, Feliciello, Giancarlo, Varadarajan, Adithi Ravikumar, Lu, Xin, Weidele, Kathrin, Botteron, Catherine, Materna-Reichelt, Silvia, Keil, Felix, Evert, Katja, Weber, Florian, Schamberger, Thomas, Althammer, Michael, Grosse, Jirka, Hellwig, Dirk, Schulz, Christian, Seitz, Stephan, Ugocsai, Peter, Schlenska-Lange, Anke, Mayr, Roman, Kaiser, Ulrich, Dietmaier, Wolfgang, Polzer, Bernhard, Warfsmann, Jens, Honarnejad, Kamran, Pukrop, Tobias, Heudobler, Daniel, Klein, Christoph A, Werno, Christian

Volltext

Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFRmut NSCLC in diagnosis, follow-up and treatment von Lüke, Florian, Blazquez, Raquel, Yamaci, Rezan Fahrioglu, Lu, Xin, Pregler, Benedikt, Hannus, Stefan, Menhart, Karin, Hellwig, Dirk, Wester, Hans-Jürgen, Kropf, Saskia, Heudobler, Daniel, Grosse, Jirka, Moosbauer, Jutta, Hutterer, Markus, Hau, Peter, Riemenschneider, Markus J., Bayerlová, Michaela, Bleckmann, Annalen, Polzer, Bernhard, Beißbarth, Tim, Klein, Christoph A., Pukrop, Tobias

Volltext

Additional file 2 of Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth von Keller, Magdalena, Rohlf, Katharina, Glotzbach, Annika, Leonhardt, Gregor, Lüke, Simon, Derksen, Katharina, Demirci, Özlem, Göçener, Defne, AlWahsh, Mohammad, Lambert, Jörg, Lindskog, Cecilia, Schmidt, Marcus, Brenner, Walburgis, Baumann, Matthias, Zent, Eldar, Zischinsky, Mia-Lisa, Hellwig, Birte, Madjar, Katrin, Rahnenführer, Jörg, Overbeck, Nina, Reinders, Jörg, Cadenas, Cristina, Hengstler, Jan G., Edlund, Karolina, Marchan, Rosemarie

Volltext bestellen

Additional file 4 of Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth von Keller, Magdalena, Rohlf, Katharina, Glotzbach, Annika, Leonhardt, Gregor, Lüke, Simon, Derksen, Katharina, Demirci, Özlem, Göçener, Defne, AlWahsh, Mohammad, Lambert, Jörg, Lindskog, Cecilia, Schmidt, Marcus, Brenner, Walburgis, Baumann, Matthias, Zent, Eldar, Zischinsky, Mia-Lisa, Hellwig, Birte, Madjar, Katrin, Rahnenführer, Jörg, Overbeck, Nina, Reinders, Jörg, Cadenas, Cristina, Hengstler, Jan G., Edlund, Karolina, Marchan, Rosemarie

Volltext bestellen